Jeff Mason is a White House Correspondent for Reuters and the 2016-2017 president of the White House Correspondents’ Association. He was the lead Reuters correspondent for President Barack Obama's 2012 campaign and interviewed the president at the White House in 2015. Jeff has been based in Washington since 2008, when he covered the historic race between Obama, Hillary Clinton and John McCain. Jeff started his career in Frankfurt, Germany, where he covered the airline industry before moving to Brussels, Belgium, where he covered the European Union. He is a Colorado native, proud graduate of Northwestern University and former Fulbright scholar.
Twitter handle: @jeffmason1
MUMBAI A member of the Indian parliament wrote a letter to Prime Minister Narendra Modi on Thursday urging him to cap the prices of 20 medical devices to bring down hospitalisation costs and make healthcare more affordable.
By Zeba Siddiqui, Krishna N. Das, Tommy Wilkes and Tom Lasseter
COX'S BAZAR, Bangladesh Sitting in his hillside grocery shop in a Bangladesh refugee camp, Rohingya Muslim Momtaz-ul-Hoque takes a break to listen to an audio recording on his mobile phone, while children and passers-by gather round to hear the latest news from Myanmar. | Video
COX'S BAZAR/YANGON Hungry, destitute and scared, thousands of new Rohingya refugees crossed the border into Bangladesh from Myanmar early on Monday, Reuters witnesses said, fleeing hunger and attacks by Buddhist mobs that the United Nations has called ethnic cleansing.
MUMBAI India has given Chinese smartphone maker Oppo the go-ahead to open its own single-brand retail stores, boding well for rivals like Apple Inc which are seeking similar approvals.
MUMBAI India's drug pricing authority called for better regulation of the country's massive private healthcare industry on Friday to ensure government efforts to cut prices benefit patients.
BEIJING/MUMBAI Shanghai Fosun Pharmaceutical Group is trimming the size of the stake it will buy in India's Gland Pharma to 74 percent for $1.1 billion, in a bid to salvage the stalled deal that would be the biggest takeover by a Chinese firm in India.